Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Ormiston

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Current Cardiology Reports|July 6, 2011
Revascularization for unprotected left main coronary artery disease: an evolution in clinical decision makingDavid E Kandzari, John A Ormiston
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 17, 2022
The Polyzene-F Stent Coating Improves Healing and Outcomes Preclinically, but Is It Effective Clinically?John A Ormiston, Jonathon M White
Journal of the American College of Cardiology|January 17, 2009
Statistical methodology used in the TAXUS ATLAS TrialMark A Turco, John A Ormiston
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 21, 2018
It seemed like a good idea at the timeJohn A Ormiston, Mark W Webster
Lancet (London, England)|September 18, 2007
Drug-eluting stents and late stent thrombosisMark W I Webster, John A Ormiston
Lancet (London, England)|March 27, 2012
Stent thrombosis: has the firestorm been extinguished?John A Ormiston, Mark W I Webster
Circulation. Cardiovascular Interventions|August 12, 2016
Of Stents and Scaffolds: Trial Data and the Real WorldJohn A Ormiston, Mark W I Webster
Lancet (London, England)|March 17, 2010
Sorting out drug-eluting stentsMark W I Webster, John A Ormiston
Lancet (London, England)|January 21, 2015
Drug-eluting stents--SORTedMark W I Webster, John A Ormiston
Circulation. Cardiovascular Interventions|December 25, 2009
Bioabsorbable coronary stentsJohn A Ormiston, Patrick W S Serruys
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Current Cardiology Reports|July 6, 2011
Revascularization for unprotected left main coronary artery disease: an evolution in clinical decision makingDavid E Kandzari, John A Ormiston
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 17, 2022
The Polyzene-F Stent Coating Improves Healing and Outcomes Preclinically, but Is It Effective Clinically?John A Ormiston, Jonathon M White
Journal of the American College of Cardiology|January 17, 2009
Statistical methodology used in the TAXUS ATLAS TrialMark A Turco, John A Ormiston
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 21, 2018
It seemed like a good idea at the timeJohn A Ormiston, Mark W Webster
Lancet (London, England)|September 18, 2007
Drug-eluting stents and late stent thrombosisMark W I Webster, John A Ormiston
Lancet (London, England)|March 27, 2012
Stent thrombosis: has the firestorm been extinguished?John A Ormiston, Mark W I Webster
Circulation. Cardiovascular Interventions|August 12, 2016
Of Stents and Scaffolds: Trial Data and the Real WorldJohn A Ormiston, Mark W I Webster
Lancet (London, England)|March 17, 2010
Sorting out drug-eluting stentsMark W I Webster, John A Ormiston
Lancet (London, England)|January 21, 2015
Drug-eluting stents--SORTedMark W I Webster, John A Ormiston
Circulation. Cardiovascular Interventions|December 25, 2009
Bioabsorbable coronary stentsJohn A Ormiston, Patrick W S Serruys
Pageof 13